Uhmontpellier
Montpellier, 34295, France
NCT Number: NCT03137563
This trial aimed at evaluating the acceptability of HPV self-sampling among french women eligible for cervical cancer screening (25 - 65 years old) in the region of Occitanie, in the south of France. Acceptability will be evaluated using an anonymous questionnaire and the main outcome of the study will be the response acceptability " yes " or " no " for HPV self-sampling. Secondary outcome will be analysis of socioeconomic determinants for the acceptability of HPV self-sampling.
These data will help to propose new strategies for cervical cancer screening in France, particularly to taget non-attenting populations
Looking for future studies?
Notify Me25 year–65 year
Female
Observational
Montpellier, 34295, France
Women will be recruted in 8 centers located in 2 departments , Aude and Herault (in the Region of Occitanie in the south of France).The questionnaire will be proposed to the women attending one of these eight centers by an investigator, who will verify the inclusion and exclusion criteria. The same person will collect the filled questionnaire.
The questionnaire is anonymous and is composed of 15 questions evaluating the acceptability of HPV self-sampling and socio-economic determinants.
These questionnaires will be collected and statistical analysis will be performed using appropriate tools.
This study will bring informations on the acceptibility of HPV self sampling among french women eligible for cervical cancer screening in 2 Departements of the South of France. Self-sampling acceptability will be linked to socio-economic determinants.
These data will be important to propose and evaluate new strategies to improve screening coverage, particularly of the context of the organized cervical cancer screening that will take place in France in 2018.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
The questionnaire will be distributed and collected by the same investigator in one of the eight centers involved in the study. The investigator will verify the inclusion criteria and the absence of exclusion criteria.
Other names: Distribution of an anonymous questionnaire
Time frame: 1 day
Response " Yes " or " No " to the question " would you accept HPV self-sampling for cervical cancer screening ?
Time frame: 1 day
Socioeconomic determinants of the response " yes " or " no " to the question " would you accept HPV self-sampling for cervical cancer screening ?
University Hospital, Montpellier
Other
Evaluation of the Acceptability of HPV Self-sampling Among French Women Eligible for Cervical Cancer Screening
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04927494
Cervical Cancer, Female Urogenital Diseases
Lexington, Kentucky, United States
View Trial DetailsNCT07521163
Adherence Interventions, Behavior
Van, Turkey (Türkiye)
View Trial DetailsNCT07398313
Cervical Adenocarcinoma, Cervical Cancer
Chennai, Tamil Nadu, India
View Trial DetailsNCT04287868
Anal Cancer, Anus Diseases
Bethesda, Maryland, United States
View Trial Details